Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 247 publications
Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis.
Journal: Cancer research communications
Published: April 02, 2026
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 13, 2026
Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.
Journal: Blood
Published: January 05, 2026
Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World Experience.
Journal: EJHaem
Published: December 15, 2025
A glycoengineered anti-ROR1 antibody, GE-zilovertamab, selectively enhances antibody-dependent cellular cytotoxicity against chronic lymphocytic leukemia.
Journal: Antibody therapeutics
Published: September 03, 2025
Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia.
Journal: HemaSphere
Published: June 06, 2025
The mutational landscape and functional effects of noncoding ultraconserved elements in human cancers.
Journal: Science advances
Published: February 19, 2025
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2025
Last Updated: 09/26/2026